Wnt-targeted hair loss treatment
Scope
Date
~
-
Bio & Pharma
ToolGen, ANLBIO to jointly develop progeria treatments
South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...
Dec 21, 2022 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Systems to build network to share land, sea, air target info
South Korea's Hanwha Systems Co. will start domestic research and development of new tactical data links used by member countries of the North Atlan...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
Seegene's COVID-19 diagnostic product wins Product of the Year Award
Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum ...
Dec 16, 2022 (Gmt+09:00)
-
Corporate strategy
Samsung eyes new mobile AP chip to take on Apple's iPhone
Samsung Electronics Co. and Apple Inc. have had a long rivalry in the global market for smartphones and other mobile devices. In terms of sales...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem in $95.5 million drug out-licensing deal with China’s Innovent
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer
South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Korean food
Sulbing opens 1st US store in California in March next year
South Korean dessert café Sulbing said on Friday that it signed a new master franchise contract to declare its entry into the US market and a...
Dec 09, 2022 (Gmt+09:00)
-
Travel & Leisure
Lordsystem, NHN Doctortour agree to promote mobile passport authentication service
South Korea’s two companies, Lordsystem and NHN Doctortour, decided to cooperate on mobile passport identity verification services, which wi...
Dec 09, 2022 (Gmt+09:00)
-
Leadership & Management
Samsung tightens belt to gird for worsening economic conditions
Samsung Electronics Co., the world’s largest memory chip and smartphone maker, is drastically cutting costs while maintaining investments in f...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals launches epilepsy drug in France
South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...
Dec 09, 2022 (Gmt+09:00)
-
Beauty & Cosmetics
Shinsegae Int'l secures domestic sales rights for Italian brand Davines
South Korea's fashion retail giant Shinsegae International on Monday said it has acquired the domestic rights to sell the Italian haircare brand Dav...
Dec 06, 2022 (Gmt+09:00)
-
Shipping & Shipbuilding
Korean shipbuilder KSOE wins $308 million order for 2 ethane carriers
Korea Shipbuilding & Offshore Engineering (KSOE), the holding company of the world’s top shipbuilder Hyundai Heavy Industries Group, said ...
Dec 02, 2022 (Gmt+09:00)
-
Supply chain
Korea’s industrial losses balloon to $1.2 bn as truckers continue strike
South Korea’s manufacturing sector faces ballooning losses across industries as the trucker strike entered its eighth day on Thursday, disrupt...
Dec 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion to enter dental disease treatment sector
Orion Corp., the Korean company, best known for its signature product choco pie, is entering drug development. Instead of indirectly running a joint...
Nov 30, 2022 (Gmt+09:00)
-
Pension funds
NPS posts 7% investment loss in Q1-Q3 as equities, bonds plunge
National Pension Service (NPS) of South Korea said Tuesday it saw a cumulative loss of 7.1% on investment, or 68 trillion won ($51.3 billion), betwe...
Nov 29, 2022 (Gmt+09:00)
-
Korean startups
Sandbox Network pursues corporate restructuring to dig out of red
Sandbox Network, Inc. announced on Sunday that it will go through corporate restructuring and encourage employees to voluntarily resign, hit by cont...
Nov 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins trial against Regeneron for US patent lawsuit over biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...
Nov 18, 2022 (Gmt+09:00)
-
Waste management
BKT thrives as lone Korean wastewater treatment provider in US
South Korean water treatment provider Bukang Tech(BKT) on Wednesday said it earned a contract to build a wastewater treatment facility in the US sta...
Nov 18, 2022 (Gmt+09:00)
-
Foreign exchange
Korean exporters suffer FX derivate losses on weak won
More South Korean exporters suffered massive losses from foreign exchange derivatives on a weaker won, failing to benefit from the unit’s depr...
Nov 17, 2022 (Gmt+09:00)
-
IPOs
Miniforce producer aims to become Asia's top children's platform with IPO
The South Korean producer of famous animated series such as Miniforce aims to become Asia’s top children's platform by way of an initial publi...
Nov 15, 2022 (Gmt+09:00)
-
Earnings
KEPCO to see record loss 2022 on slower power tariff hikes
Korea Electric Power Corp. (KEPCO), the state-run utility, is set to suffer a record operating loss this year with a shortfall mounting to the secon...
Nov 11, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharma's epilepsy treatment posts impressive growth in US
South Korean SK Biopharmaceuticals' epilepsy treatment Cenobamate has seen rapid growth on the US market.The company on Thursday said the medic...
Nov 11, 2022 (Gmt+09:00)
-
Investment banking
Korean brokerages' restructuring targets investment banking units
South Korea’s small- and mid-sized brokerage houses have begun their workforce reductions ahead of the end of the year. The brokerages are set...
Nov 10, 2022 (Gmt+09:00)
-
Korean startups
Danggeun Market launches professional advertising solution
South Korean startup Danggeun Market, the operator of the country’s largest neighborhood marketplace app Karrot, is ramping up efforts to incr...
Nov 10, 2022 (Gmt+09:00)
-
Companies
US water treatment juggernaut Culligan eyes Chungho Nais stake
Culligan, the biggest water treatment company in the United States, is set to become a major shareholder in South Korean water purifier rental firm ...
Nov 09, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Microsoft CEO Nadella to speak at developers' forum in Seoul
Microsoft Korea said on Tuesday that it will host Microsoft Ignite Spotlight on Korea, an annual conference for developers and IT professionals, on ...
Nov 08, 2022 (Gmt+09:00)
-
Earnings
Kakao's Q3 profit drops 12% on games, data center construction
South Korea’s mobile platform giant Kakao Corp. announced its third-quarter earnings on Nov. 3, including quarterly operating profit of 150.3 ...
Nov 04, 2022 (Gmt+09:00)
-
Korean food
Want to improve memory? Eat more ginseng
Consumption of ginseng and red ginseng (hongsam) can improve memory capacity and prevent high blood pressure, diabetes and muscle loss, according to...
Nov 02, 2022 (Gmt+09:00)